Stocks
Pfizer (PFE) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 37.9% | 40.9% | 16.0% | 28.5% | 24.1% | 26.8% | ||
| Changes by years, y/y, % | +6pp | +3pp | -25pp | +12pp | -4pp | -5.1% | |||
Pfizer. EBITDA margin, %
Pfizer. EBITDA margin, changes, pp
Pfizer (PFE) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 36.3% | 33.9% | 4.31% | 36.1% | 26.8% | ||
| Changes by years, y/y, % | -40pp | +18pp | -7pp | -25pp | ||||
| Changes by quarters, q/q, % | -29pp | -2pp | -30pp | +32pp | ||||
